About 50% of triple-negative breast cancer (TNBC) patients develop resistance to therapy. When resistance arises, tumors are more likely to come back ...

A study published in Molecular Psychiatry reveals a path of cause-effect molecular events that can lead to Alzheimer’s ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial. The TACTOPS trial, which ...

First responders encounter difficult, traumatic events in times of emergency and crisis. They help people on the worst days of their lives and are exposed to some of the most dangerous situations, ...

An international research team led by Baylor College of Medicine and The University of Osaka have found a way to resume sperm production, leading to healthy offspring in mouse models with ...

Researchers at Baylor College of Medicine, Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital, Stanford University School of Medicine and collaborating ...

The National Endowment for the Humanities (NEH) has awarded a $500,000 grant to Baylor College of Medicine and Rice University to establish the Center for Humanities-based Health AI Innovation (CHHAIN ...

Although metformin has been the go-to medication to manage type 2 diabetes for more than 60 years, researchers still do not have a complete picture of how it works. Scientists at Baylor College of ...

A compound found in psychedelic mushrooms may have antiaging properties. Researchers at Baylor College of Medicine have found that psilocybin, the active compound in psychedelic mushrooms, may extend ...

Surgeons at Baylor St. Luke's Medical Center successfully performed a fully robotic heart transplant on an adult patient – the first reported in the United States. Using a surgical robot, lead surgeon ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators from Baylor College of Medicine, ...

A new study published in the journal Nature reports results of the first-in-human phase 1 clinical trials of a novel immunotherapy approach for solid tumors expressing glypican-3 (GPC3). Researchers ...